Štěpánková Jana

Štěpánková Jana's picture
Bachelor training
Preclinical development of 68Ga labelled peptides for glioblastoma imaging
This work is focused on preclinical testing of selected peptides labelled with 68Ga as potential radiodiagnostics for glioblastoma multiforme. The main goal of the study is to determine in vitro characteristics of studied peptides, their in vivo behaviour in mice and to evaluate the potential of 68Ga labelled peptides for diagnosis of glioblastoma multiforme using positron emisson tomography.

Status:

Graduated 2014 - 2015

Publications (Impact Factor Journals):


Patents, Utility models & other IP's :

[1] CHOLYL HYDRAZONES AND THEIR USE IN THE TREATMENT OF TUMOR AND LEUKEMIA DISEASES, Priority Appl. CZ PV 2014-305
  1. Patent: CZ 305 607, Granted: 25. 11. 2015, Ownership: Institute of Chemical technology Prague, Institute of molecular genetics AS CR, Palacky University OlomoucInventors: Rak Jakub, Kaplánek Robert, Štulcová Tereza, Drašar Pavel, Havlík Martin, Bříza Tomáš, Džubák PetrHajdúch MariánKonečný PetrŠtěpánková Jana, Králová Jarmila, Král Vladimír

Status: Available